Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
The primary objective of this pilot study is to assess PAI-performance in a clinical setting to understand limitations of our current PAI instrumentation and to help improve the next-generation design.
To do preliminary evaluations of oxygen saturation in lesions based on PAI-measurements in order to distinguish malignant from benign prostatic tissue as a basis for future studies.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study|
- lesion signal intensity on Photoacoustic Imaging (PAI) in relation to different lesion characteristics and the surrounding tissues [ Time Frame: 36 months ] [ Designated as safety issue: No ]The types of measures can be divided into three groups: 1) Operator determined measures during or just after the examination; 2) Post processing measures determined during post processing of the captured data and images; 3) Measures related to standard imaging and histopathological examination.
|Study Start Date:||February 2014|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01551576
|Contact: Jonathan Wufirstname.lastname@example.org|
|United States, California|
|Stanford University Cancer Institute||Recruiting|
|Stanford, California, United States, 94305|
|Contact: Stanford Cancer Clinical Trials Office 650-498-7061 email@example.com|
|Sub-Investigator: James D Brooks, MD|
|Sub-Investigator: Benjamin I Chung, MD|
|Sub-Investigator: Harcharan Gill, MD|
|Sub-Investigator: Mark L Gonzalgo, MD|
|Sub-Investigator: Joseph C Presti, MD|
|Principal Investigator:||Sanjiv S Gambhir, MD||Stanford University|
|Principal Investigator:||Sri R Kothapalli, MD||Stanford University|